These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17554504)

  • 1. Immune plasticity of bone marrow-derived mesenchymal stromal cells.
    Stagg J; Galipeau J
    Handb Exp Pharmacol; 2007; (180):45-66. PubMed ID: 17554504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune regulation by mesenchymal stem cells: two sides to the coin.
    Stagg J
    Tissue Antigens; 2007 Jan; 69(1):1-9. PubMed ID: 17212702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
    Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
    Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of immune responses by mesenchymal stem cells.
    Fibbe WE; Nauta AJ; Roelofs H
    Ann N Y Acad Sci; 2007 Jun; 1106():272-8. PubMed ID: 17442776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune modulation by mesenchymal stem cells.
    Rasmusson I
    Exp Cell Res; 2006 Jul; 312(12):2169-79. PubMed ID: 16631737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
    Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
    Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
    Phinney DG; Prockop DJ
    Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells.
    Bernardo ME; Locatelli F; Fibbe WE
    Ann N Y Acad Sci; 2009 Sep; 1176():101-17. PubMed ID: 19796238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells: a new strategy for immunosuppression?
    Uccelli A; Pistoia V; Moretta L
    Trends Immunol; 2007 May; 28(5):219-26. PubMed ID: 17400510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
    Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
    Beyer Nardi N; da Silva Meirelles L
    Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
    Zhao ZG; Li WM; Chen ZC; You Y; Zou P
    Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between human mesenchymal stem cells and natural killer cells.
    Sotiropoulou PA; Perez SA; Gritzapis AD; Baxevanis CN; Papamichail M
    Stem Cells; 2006 Jan; 24(1):74-85. PubMed ID: 16099998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.
    Caplan AI
    J Cell Physiol; 2007 Nov; 213(2):341-7. PubMed ID: 17620285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.